Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 77 (TRIM77) is a member of the TRIM family, characterized by an RBCC (RING, B-box, coiled-coil) structural motif, suggesting potential E3 ubiquitin ligase function involved in post-translational modification, regulation of gene expression, and innate immunity, though these functions are predicted rather than confirmed. TRIM77 is often annotated as a pseudogene or a putative protein, with no experimental evidence confirming expression, molecular function, or association with specific diseases. TRIM77 is not recognized as a validated therapeutic target or biological receptor/enzyme in human biology, and current knowledge is extrapolated from general TRIM family roles[1][2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 77 (TRIM77).